SCHEMBL26317010

SCHEMBL26317010

Cc1cc(Cc2ccccc2)cc(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.55
SRD5A2 P31213 2/20 0.50
LMNA P02545 2/20 0.50
HCAR1 Q9BXC0 1/20 0.48
PTPN1 P18031 3/20 0.46
PTPN2 P17706 1/20 0.46
PTPN6 P29350 1/20 0.46
PLA2G10 O15496 1/20 0.46
PLA2G2A P14555 1/20 0.46
POLB P06746 2/20 0.45
KDM4E B2RXH2 1/20 0.45
IDH1 O75874 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HNF4A P41235 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.45
FOLH1 Q04609 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19708760 0.91 TPMT (0.67) TPMTSRD5A2HCAR1POLBKDM4E
SCHEMBL27916834 0.87 PLA2G10 (0.53) SRD5A2LMNAPTPN1PTPN2PTPN6
SCHEMBL2142442 0.87 PLA2G10 (0.53) SRD5A2LMNAPTPN1PTPN2PTPN6
SCHEMBL19272809 0.85 UNG (0.51) TPMTSRD5A2LMNAHCAR1MRGPRX4
SCHEMBL11816061 0.84 IDH1 (0.50) TPMTIDH1MRGPRX4FOLH1TAS2R14
SCHEMBL27383231 0.84 FOLH1 (0.56) TPMTMRGPRX4FOLH1HTTSMN1; SMN2
SCHEMBL6949748 0.81 ERCC5 (0.53) LMNAPTPN1POLBKDM4EMEN1
SCHEMBL11820851 0.81 SRD5A2 (0.61) TPMTSRD5A2IDH1MRGPRX4
SCHEMBL5027093 0.80 CALM1 (0.60) LMNAIDH1CALM1
SCHEMBL9496827 0.80 CALM1 (0.60) LMNAPTPN1PTPN2PTPN6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739112-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739112-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles FTO, TPI1, ACP1 TPMT 318/4885SRD5A2 2646/4885LMNA 4515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.